Communiqués de presse MHRA — Medicines and Healthcare products Regulatory Agency — Flux RSS et veille en direct
PPN World suit le flux RSS de MHRA — Medicines and Healthcare products Regulatory Agency en temps réel — 7 communiqués indexés au cours des 30 derniers jours, le plus récent est arrivé il y a 3 j. Suivez-le avec alertes sur recherches enregistrées, résumés IA et recherche plein texte.
Courriel quotidien gratuit
Ce qui tombe demain
Les grands événements mondiaux du lendemain, tirés de l’agenda PPN World (banques centrales, statistiques, élections, sommets), chaque soir à 17 h UTC.
Un courriel par jour. Aucun compte requis. Désabonnement en un clic.
À propos de ce fil
MHRA — Medicines and Healthcare products Regulatory Agency fait partie des 1,400+ fils de presse que PPN World surveille en continu — un fil en anglais axé sur le secteur Santé & sciences de la vie, classé sous « Royaume-Uni » dans notre index par pays. Chaque communiqué est dédupliqué, géolocalisé et enrichi d'un résumé IA, et vous pouvez y attacher des alertes sur recherches enregistrées. MHRA — Medicines and Healthcare products Regulatory Agency est un fil spécialisé à faible volume — 7 communiqués dans les 30 derniers jours : le genre de source qui mérite une alerte plutôt qu'un défilement.
Suivez MHRA — Medicines and Healthcare products Regulatory Agency en temps réel dans PPN World
Chaque communiqué de MHRA — Medicines and Healthcare products Regulatory Agency arrive dans le cockpit quelques secondes après sa publication — dédupliqué, classé, avec alertes sur recherches enregistrées et résumés IA, aux côtés de 1,400+ autres fils.
Créer un compte gratuit →Derniers communiqués de MHRA — Medicines and Healthcare products Regulatory Agency
- MHRA appoints senior NHS executive as new Chief Finance and Commercial Officeril y a 3 j
The Medicines and Healthcare products Regulatory Agency (MHRA) has appointed a new Chief Financial and Commercial Officer to drive forward the financial aspects of its new five-year strategy.
- Government backs modernisation of gene therapy definitionsil y a 3 j
Proposed changes will provide clearer regulatory pathway for certain synthetic gene therapies, supporting life sciences innovation while maintaining safety.
- New MHRA service to support medicines innovation and strengthen UK manufacturingil y a 4 j
AdvanceGxP will give developers earlier practical support for advanced manufacturing technologies, accelerating patient access to innovative medicines while strengthening UK manufacturing.
- MHRA launches new programme to tackle evidence gaps on women’s healthil y a 6 j
Women’s Health Programme aims to support innovation in women’s health and better understand how the risks and benefits of medicines and medical devices may differ for women.
- MHRA: services during Microsoft outageil y a 9 j
We have been experiencing problems sending and receiving emails.
- MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal canceril y a 10 j
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved retifanlimab (ZYNYZ) for the treatment of adults with squamous cell carcinoma of the anal canal (SCAC).
- Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathwayil y a 13 j
Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare produc…
- MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulationil y a 16 j
New plan will broaden participation and make clearer how patient experience informs regulatory decisions, safety and innovation
- MHRA guidance on its assessment of non-clinical data generated outside OECD systemil y a 17 j
MHRA issues new guidance on its approach to clinical trial applications that rely on non-clinical safety data generated outside the OECD Mutual Acceptance of Data system.
- Clinical trials for medicines: Inclusion and Diversity Plan pilot findings publishedil y a 19 j
The Health Research Authority (HRA) has published the findings from its pilot on researchers and sponsors of clinical trials and clinical investigations developing and submitting an Inclusion and Dive…
- MHRA launches patient safety essay competition for MedSafetyWeekil y a 20 j
The MHRA reminds patients, parents, carers and healthcare professionals to report suspected side effects through the Yellow Card scheme for MedSafetyWeek 2026.
- Triheptanoin (Dojolvi) approved to treat adults and children with a group of rare inherited disordersil y a 22 j
MHRA approves triheptanoin to treat adult and paediatric patients with a group of rare inherited disorders.
Les plus récents communiqués de ce fil défilent en direct pour les membres PPN World.